| RS2116581323 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116586974 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116592997 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116593187 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116594089 |
IMPDH1
|
Health Risk |
Pathogenic |
— |
| RS2116598150 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116601689 |
IMPDH1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 10, Retinitis pigmentosa 10 |
| RS2116604421 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1 |
| RS2116607774 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116608214 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2116614049 |
AP4M1
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2116614409 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116614972 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116616864 |
AP4M1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2116619497 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116619574 |
PIK3CG
|
Health Risk |
Pathogenic |
Immunodeficiency 97 with autoinflammation, Immunodeficiency 97 with autoinflammation |
| RS2116623273 |
COG5
|
Health Risk |
Likely pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS2116628120 |
AP4M1
|
Health Risk |
Pathogenic |
— |
| RS2116629474 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116630442 |
POR
|
Health Risk |
Likely pathogenic |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS2116635157 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116638179 |
CNTNAP2
|
Health Risk |
Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2116638409 |
AP4M1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2116643174 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116643224 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116643498 |
AP4M1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS2116648196 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116650029 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116654140 |
DNAJC30
|
Health Risk |
Pathogenic |
Leber-like hereditary optic neuropathy, autosomal recessive 1 |
| RS2116654445 |
DNAJC30
|
Health Risk |
Pathogenic |
Leber-like hereditary optic neuropathy, autosomal recessive 1 |
| RS2116656505 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116663520 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116668499 |
AP4M1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS2116669950 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116670123 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116670348 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS2116670615 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Norman-Roberts syndrome |
| RS2116670931 |
AP4M1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2116673209 |
MDH2
|
Health Risk |
Likely pathogenic |
— |
| RS2116675185 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116676645 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116678523 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116678722 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116680039 |
KEL
|
Health Risk |
association |
Vein of Galen aneurysmal malformation, Vein of Galen aneurysmal malformation |
| RS2116683702 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116683801 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116684480 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS2116688381 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116689179 |
ABCB4
|
Health Risk |
Likely pathogenic |
— |
| RS2116691068 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2116693349 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116693521 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116694543 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116694965 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116695697 |
SGCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116695873 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116696690 |
MDH2
|
Health Risk |
Pathogenic |
— |
| RS2116717136 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116717319 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS2116722242 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116722345 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116722561 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116722961 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116723386 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116723835 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116724168 |
STX1A
|
Health Risk |
Likely pathogenic |
Autism, Intellectual disability |
| RS2116724268 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116724823 |
SGCE
|
Health Risk |
Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116724997 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116727279 |
SLC26A5
|
Health Risk |
Pathogenic |
— |
| RS2116730958 |
STX1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Seizure |
| RS2116730968 |
STX1A
|
Health Risk |
Likely pathogenic |
Autism, Intellectual disability |
| RS2116731315 |
STX1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Seizure |
| RS2116731333 |
LMOD2
|
Health Risk |
Pathogenic |
Familial isolated dilated cardiomyopathy, Cardiomyopathy |
| RS2116737208 |
STX1A
|
Health Risk |
Pathogenic |
Autism, Intellectual disability |
| RS2116752243 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2116755694 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS2116763829 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS2116773782 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS2116773941 |
KCTD7
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2116774137 |
KCTD7
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS2116775490 |
KCTD7
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS2116775509 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS2116775575 |
KCTD7
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2116783251 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Autosomal recessive nonsyndromic hearing loss 97 |
| RS2116787553 |
PODXL
|
Health Risk |
Pathogenic |
— |
| RS2116789389 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Inborn genetic diseases |
| RS2116810501 |
TRRAP
|
Health Risk |
Likely pathogenic |
— |
| RS2116815571 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS2116826038 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116833609 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS2116834548 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116835879 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS2116836321 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116836451 |
CLCN1
|
Health Risk |
Pathogenic |
— |
| RS2116837535 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116837885 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116838394 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116838620 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116842799 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal dominant form |